Guidance on HPV vaccination in EU countries: focus on boys, people living with HIV and 9-valent HPV vaccine introduction
This document summarises evidence from studies included in the licensing file of HPV vaccines together with postlicensure, peer-reviewed data and analysis where available. This guidance does not address the safety of HPV vaccines observed during the pre- and post-licensing period.
Systematic scoping review on social media monitoring methods and interventions relating to vaccine hesitancy
Understanding vaccine hesitancy and social media: which social media platforms do users preferably choose as source of information on vaccination and how does that influence their perceptions of vaccination? A systematic scoping review by ECDC and the Vaccine Confidence Project summarises knowledge and research on social media and vaccination.
Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016–17 and 2017–18)
Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Rizzo, C., Gherasim, A., Horváth, J.K., Brytting, M., Domegan, L., Meijer, A., Paradowska-Stankiewicz, I., Machado, A., Vučina, V.V., Lazar, M., Johansen, K., Dürrwald, R., van der Werf, S., Bella, A., Larrauri, A., Ferenczi, A., Zakikhany, K., O'Donnell, J., Dijkstra, F., Bogusz, J., Guiomar, R., Filipović, S.K., Pitigoi, D., Penttinen, P., Valenciano, M.
Influenza communication guide: How to increase influenza vaccination uptake and promote preventive measures to limit its spread
The influenza vaccination communication guide provide advice, guidance and campaign materials to support national influenza vaccination campaigns with the purpose of increasing the influenza vaccination uptake in the EU Member States.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15-64-year-olds in Europe: exploration by birth cohort
Kissling, E., Pozo, F., Buda, S., Vilcu, A.-M., Gherasim, A., Brytting, M., Domegan, L., Gómez, V., Meijer, A., Lazar, M., Vučina, V.V., Dürrwald, R., van der Werf, S., Larrauri, A., Enkirch, T., O'Donnell, J., Guiomar, R., Hooiveld, M., Petrović, G., Stoian, E., Penttinen, P., Valenciano, M., I-Move Primary Care Study Team
Children Immunization App (CIMA) among Syrian refugees in Zaatari Camp, Jordan: Protocol for a cluster randomized controlled pilot trial intervention study
Khader, Y.S., Laflamme, L., Schmid, D., El-Halabi, S., Abu Khdair, M., Sengoelge, M., Atkins, S., Tahtamouni, M., Derrough, T., El-Khatib, Z.
Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines
Sturkenboom M, Bahri P, Chiucchiuini A, Grove Krause T, HahnÃ© S, Khromava A, Kokki M, Kramarz P, Kurz X, Larson HJ, de Lusignan S, Mahy P, Torcel-Pagnon L, Titievsky L, Bauchau V; ADVANCE consortium..
Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area
Tavoschi, L., Mason, L., Petriti, U., Bunge, E., Veldhuijzen, I., Duffell, E.
Hepatitis b and c prevalence and incidence in key population groups with multiple risk factors in the EU/ EEA: A systematic review
Mason, L.M.K., Duffell, E., Veldhuijzen, I.K., Petriti, U., Bunge, E.M., Tavoschi, L.
Risk assessment: Who is at risk of measles in the EU/EEA?
A large epidemic of measles has affected the EU/EEA Member States in the past three years, with 44 074 cases reported to ECDC by 30 Member States between 1 January 2016 and 31 March 2019.